Cabot (NYSE:CBT) Price Target Raised to $70.00

Cabot (NYSE:CBT) had its price target boosted by JPMorgan Chase & Co. from $68.00 to $70.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an underweight rating on the specialty chemicals company’s stock.

A number of other research analysts have also recently issued reports on CBT. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. UBS Group raised their price target on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Mizuho raised their price target on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 price target on shares of Cabot in a report on Wednesday, February 4th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Cabot has a consensus rating of “Hold” and a consensus price target of $80.25.

Cabot Trading Down 1.3%

NYSE:CBT opened at $81.04 on Wednesday. Cabot has a 52 week low of $58.33 and a 52 week high of $86.43. The firm has a 50 day moving average of $74.88 and a 200 day moving average of $70.96. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $4.18 billion, a price-to-earnings ratio of 15.32, a PEG ratio of 10.74 and a beta of 0.78.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. The business had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.31 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business’s quarterly revenue was down 3.4% on a year-over-year basis. During the same quarter last year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, sell-side analysts anticipate that Cabot will post 6.32 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 29th will be issued a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend is Friday, May 29th. Cabot’s dividend payout ratio is 34.03%.

Institutional Trading of Cabot

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Lazard Asset Management LLC grew its position in Cabot by 96.2% during the first quarter. Lazard Asset Management LLC now owns 43,219 shares of the specialty chemicals company’s stock valued at $3,255,000 after buying an additional 21,194 shares during the period. Lombard Odier Asset Management USA Corp acquired a new stake in Cabot during the first quarter valued at $283,000. Morningstar Investment Management LLC grew its position in Cabot by 47.6% during the first quarter. Morningstar Investment Management LLC now owns 8,681 shares of the specialty chemicals company’s stock valued at $654,000 after buying an additional 2,799 shares during the period. Sei Investments Co. grew its position in Cabot by 6.5% during the first quarter. Sei Investments Co. now owns 1,051,578 shares of the specialty chemicals company’s stock valued at $79,194,000 after buying an additional 64,122 shares during the period. Finally, Cetera Investment Advisers grew its position in Cabot by 6.5% during the first quarter. Cetera Investment Advisers now owns 34,134 shares of the specialty chemicals company’s stock valued at $2,571,000 after buying an additional 2,079 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.